Vaccination News

There have been some reports of necrosis at the injection site following receipt of the 23-valent pneumococcal vaccine, but the vaccine’s overall benefit-risk balance “remains favorable,” researchers wrote in JAMA Internal Medicine.

Takeda’s dengue vaccine candidate is no longer under review for approval in the United States.

A study of more than 50 adults with a serious inflammatory syndrome linked to SARS-CoV-2 infection found that fewer than half were diagnosed with the condition while they were hospitalized.

ORLANDO — A mid-sized university with a universal masking mandate saw no increase in COVID-19 after eliminating physical distancing requirements, according to study findings.

The introduction of eight WHO-recommended vaccines into national immunization schedules slowed during the COVID-19 pandemic, researchers reported in MMWR.

Moderna has initiated the rolling submission process for its respiratory syncytial virus vaccine candidate mRNA-1345, the company announced Wednesday.

A Pittsburgh hospital curbed neurosurgical infections by more than 80% over 2 years through a multidisciplinary intervention that assessed adherence to surgical site infection prevention recommendations, data show.

Wellcome and the Bill & Melinda Gates Foundation announced Wednesday that they will provide up to $550 million in funding for a phase 3 trial of a tuberculosis vaccine candidate.

Although rare in travelers, nearly all complicated cases of dengue showed warning signs, highlighting the importance of monitoring patients with dengue to prevent severe disease, according to researchers.

CDC advisors on Thursday unanimously supported the addition of Pfizer’s 20-valent pneumococcal vaccine as an option for children in the United States.